COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,762 Articles (22,946 medRxiv, 8,816 bioRxiv)

Most recent first Previous |  Page 19: Articles 181-190  | Next

Pooled testing for SARS-CoV-2 surveillance in schools: real-world evaluation of transmission control, testing resources, and educational disruption
Colosi, E., Calmon, L., Fässli, M., Koch, K., Bielicki, J. A., Colizza, V.
10.64898/2026.06.03.26354821 — Posted: 2026-06-04
Insights from Wastewater Surveillance of SARS-CoV-2 in Skilled Nursing Facilities: Comparing Virus Concentration Methods for Wastewater and Correlating Wastewater Virus Concentrations with Clinical Infections, Georgia, USA, 2022
Whitehill, F., Lyons, A. K., Abera, B., Adler, C., Burgos-Garay, M., Campbell, M., Santiago, A. J., Ganim, C., Moore, J., Cahela, Y., Lenz, S., Gable, P., Medrzycki, M., Walters, M. S., Keaton, A., Cook, P. W., Li, Y., Tao, Y., Zhang, J., Malapati, L., Retchless, A. C., Tong, S., Williams, M., Donlan, R., Coulliette-Salmond, A.
10.64898/2026.06.01.26354622 — Posted: 2026-06-04
Interferon-gamma induced RNF213 targets nascent double membrane vesicles to inhibit coronavirus primary translation
Tartell, M. A., Tissawak, R., Voss, L., Lodha, M., Bianco, C., Iwamoto, M., Poston, D., Hatziioannou, T., Weisblum, Y., Bieniasz, P. D.
10.64898/2026.06.02.729663 — Posted: 2026-06-04
A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization
Zang, T., Baharani, V. A., Aldis, M., Canis, M., Patejak, R., Osei Kuffour, E., Hoffman, H. H., van Bakel, H., Sordillo, E. M., Simon, V., MacDonald, M. R., Rice, C. M., Nussenzweig, M. C., Haziionannou, T., Bieniasz, P. D.
10.64898/2026.06.03.729821 — Posted: 2026-06-04
Systems-Scale Structural Modeling Reveals the Germline Architecture of Immunodominance
Shrock, E. L., Sun, E., Dhindsa, A., Witwer, M. H., Yu, Z., Ivanochko, D., Lee, I.-H., Coventry, B., Borras Gonzalez, M., Julien, J.-P., Elledge, S. J., Baker, D.
10.64898/2026.06.02.729678 — Posted: 2026-06-04
No objective evidence of neuropsychological deficits in people with subjective cognitive changes following COVID-19 infection
Abram, S., Dal Bon, K., Mathalon, D. H., Fryer, S. L., Song, S., Naeem, Z., Tang, N., Pulliam, L., Ford, J. M.
10.64898/2026.06.03.723612 — Posted: 2026-06-04
Hierarchical classification of immune cell transcriptomes at population-scale
Beltz, C., Qiu, Z., Sadowski, L., Kraske, J. A., Aggarwal, A., Quintanal-Villalonga, A., Manoj, P., Littbarski, A., Bajaj, S., Meskauskaite, B., Umeda, S., Mazutis, L., Rose, S. A., Chan, J. M., Nawy, T., Nainys, J., Chaligne, R., de Stanchina, E., Kaelber, K. A., Cussigh, C. S., Kallenberger, S. M., Williams, A., Jenzer, M., Pompecki, T., Kahle, S., Hohmann, N., Nussbaum, D. P., Moss, N. S., Ziv, E., Berger, A. K., Springfeld, C., Zschaebitz, S., Hassel, J. C., Debus, J., Jaeger, D., Iacobuzio-Donahue, C. A., Ganesh, K., Peer, D., Ungerechts, G., Rudin, C. M., Huber, P. E., Walle, T.
10.64898/2026.05.30.728980 — Posted: 2026-06-04
Rationale and Design of RECOVER-ENERGIZE: A Platform Clinical Trial of Interventions for Exercise Intolerance With and Without Post-exertional Malaise in Long COVID
Friedly, J., Bateman, L., Berdan, L. G., Casaburi, R., Erdmann, N., Felker, G. M., Itchon-Ramos, N., Keteyian, S. J., MacIntyre, N. R., OBrien, L., Reist, C., Rossiter, H. B., Silverstein, A. P., Taylor, E., Pike Welch, H., Yanez, N. D., Zimmerman, K. O., Make, B.
10.64898/2026.06.02.26354455 — Posted: 2026-06-03
Simple cumulative weighting of routine surveillance data identifies epidemic wave origins more accurately than a large language model: evidence from eight COVID-19 waves in Japan
Nakagawa, S., Yamamoto, A.
10.64898/2026.06.02.26354691 — Posted: 2026-06-03
SARS-CoV-2 BA.3.2.2 is more evasive of neutralization by sera from young children
Wu, M., Hong, H., Guo, Y., Daniel, K., Hisner, R., Johnson, M. C., Gordon, A., Ho, D. D., Mellis, I. A.
10.64898/2026.06.01.728533 — Posted: 2026-06-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).